Articles tagged "Liver transplantation"

2017 American Transplant Congress
Outcomes of Active Screening for Carbapenem-Resistant Enterobacteriaceae among Liver Transplant Recipients.
T. Bias,¹ G. Malat,¹ D. Lee,² S. Talluri,² K. Ranganna,² S. Epstein,² V. Patel,² S. Guy.³
¹Department of Pharmacy, Drexel University College of Medicine, Philadelphia, PA; ²Department of Medicine, Drexel University College of Medicine, Philadelphia, PA; ³Department of Surgery, Drexel University College of Medicine, Philadelphia, PA
Background: Preventive strategies to combat the transmission of Carbapenem-Resistant Enterobacteriaceae (CRE) include the use of active screening for CRE colonization; however, this approach is not…
2017 American Transplant Congress
Risk Factors and Outcomes of Intracardiac Thrombosis During Orthotopic Liver Transplantation.
W. Al-Darzi, M. El-Atrache, F. Georgie, O. Sadiq, S. Singla, C. Fernandez, R. Pompa, D. Galusca, A. Yoshida, S.-M. Jafri.
Henry Ford Hospital, Detroit, MI
Introduction: Intracardiac Thrombosis (ICT) during Orthotopic Liver Transplantation (OLT) is an uncommon event associated with high mortality. The incidence of ICT during OLT is estimated…
2017 American Transplant Congress
Heterotopic Auxiliary Liver Transplantation(ALTx) – Revisited.
V. Kirchner, E. Minja, S. Chinnakotla, R. Kandaswamy, W. Payne, T. Pruett.
University of Minnesota, Minneapolis
Background:Although, ALTx for acute liver failure(ALF) has been described over 30yrs ago, utilization of operation has been limited. Benefit of operation is to provide bridge…
2017 American Transplant Congress
Rapid Regression of Xanthomata After Orthotopic Liver Tranplantation for Alagille Syndrome.
N. Galvan,¹ P. Nguyen,¹ S. Koohmaraie,² R. Cotton,¹ A. Rana,¹ C. O'Mahony,¹ J. Goss.¹
¹Division of Abdominal Transplant, Baylor College of Medicine, Houston, TX; ²Texas Children's Hospital, Houston, TX
Arteriohepatic dysplasia, or Alagille syndrome, is a genetic disorder characterized by chronic cholestasis in the setting of multiple congenital abnormalities of different organ systems, including…
2017 American Transplant Congress
Liver Transplantation Beyond MELD 40.
J. Scalea, D. Bruno, S. Hanish, J. Lamattina, J. Alvarez-Casas, S. Malik, A. Cimeno, S. Bartlett, R. Barth.
Surgery, University of Maryland, Baltimore, MD
OBJECTIVE(S): Liver allocation is prioritized for the sickest patients; however, poorer liver transplant (LTx) outcomes are associated with increasing MELD scores. While MELD is capped…
2017 American Transplant Congress
Neuropeptide PACAP Prevents Hepatocyte Damage by Promoting Yes-Associated Protein (YAP) in Mouse Liver Ischemia/Reperfusion Injury.
Y. Liu,^1,2 C. Zhang,^1,3 R. Busuttil,¹ J. Kupiec-Weglinski,¹ Q. Xia,^1,2 H. Ji.¹
¹Department of Surgery, Dumont-UCLA Transplant Center, Los Angeles, CA; ²Liver Surgery, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China; ³Liver Surgery, 1st Affiliated Hospital, Zhejiang University, Hangzhou, China
Background: Yes-associated protein (YAP), a regulator of cellular anti-oxidation and regeneration, drives cell proliferation and promotes survival. We have previously demonstrated that neuropeptide pituitary adenylate…
2017 American Transplant Congress
Limited Impact of Pre-Existing Donor Specific HLA Antibodies on Long Term Survival After First Adult Liver Transplantation.
M. Koch,¹ M. Marget,² M. Sterneck,³ H. Thude,¹ B. Nashan.¹
¹Hepatobiliary Surgery and Transplantation, University Hospital Hamburg Eppendorf, Hamburg, Germany; ²Transfusion Medicine, University Hospital Hamburg Eppendorf, Hamburg, Germany; ³Internal Medicine I, Gastroenterology, University Hospital Hamburg Eppendorf, Hamburg, Germany
Donor specific antibodies (DSA) are known to play a pivotal role in long term kidney allograft survival. Their importance in liver transplanted patients (LTX) is…
2017 American Transplant Congress
A Pretransplant Model Incorporating Serum Biomarkers Is Superior to the Milan Criteria in Stratifying Risk of Hepatocellular Carcinoma Recurrence Following Liver Transplantation: Analysis of 4407 Patients from the US Multicenter HCC Transplant Consortium.
V. Agopian, On Behalf of the US Multicenter HCC Transplant Consortium.
UCLA, LA
Objective: While adoption of the Milan Criteria (MC) has improved outcomes following liver transplantation (LT) for hepatocellular carcinoma (HCC), recurrence remains a significant challenge. We…
2017 American Transplant Congress
A Low-Dose Anti-Hepatitis B Immunoglobulin Regimen for Prophylaxis of Hepatitis B Recurrence.
W.-C. Lee, Y.-C. Wang, C.-H. Cheng, T.-H. Wu, C.-F. Lee, T.-J. Wu, H.-S. Chou, K.-M. Chan.
Liver and Transplantation Surgery, Chang-Gung Memorial Hospital, Taoyuan, Taiwan
Background: Hepatitis B virus (HBV)-related liver disease is the major indication of liver transplantation in Asian countries. Combination of anti-hepatitis B immunoglobulin (HBIg) and anti-viral…
2017 American Transplant Congress
Vendor to Center in 0-60: A Safe and Effective Blueprint for Creating an In-House On-Call System for Organ Offers.
K. Driggers, J. Davenport, D. Cassidy, L. Curry, A. Milling, A. Hauser, H. Crego, P. Baliga, N. Pilch, D. Dubay, J. Anderson.
Transplant, Medical University of South Carolina, Charleston, SC
Introduction: Our center returned to an in-house nurse coordinator on-call program 7/2016 after using a vendor from 11/2012 to 7/2016 for organ allocation. It was…